Insiders · Profile

HERSHBERG ROBERT

Director at RECURSION PHARMACEUTICALS · Director at Adaptive Biotechnologies · Director at AtaiBeckley · and 1 more. Filing since 23 Apr 2020. CIK 0001274139

Company
Date
Role
Action
Shares
Amount
Of holding
6 Oct 2026
Director
Sold on a plan
25,000
$125.00K
13.4%
18 Aug 2026
Director
Sold at will
30,664
$748.21K
39.6%
7 Jul 2026
Director
Sold on a plan
100,000
$496.00K
50.0%
10 Dec 2025
Director
Sold at will
22,968
$367.49K
33.0%
12 Mar 2025
Director
Sold at will
53,000
$402.27K
43.2%
3 Jun 2022
Director
Sold, plan not stated
672
$15.29K
25.1%
8 Mar 2021
Director
Sold, plan not stated
4,000
$178.24K
100%
16 Feb 2021
Director
Sold, plan not stated
2,000
$130.90K
57.1%
15 Jan 2021
Director
Sold, plan not stated
2,000
$133.12K
100%
15 Dec 2020
Director
Sold, plan not stated
2,000
$111.86K
100%
16 Nov 2020
Director
Sold, plan not stated
2,000
$95.38K
100%
15 Oct 2020
Director
Sold, plan not stated
2,000
$103.02K
100%
15 Sep 2020
Director
Sold, plan not stated
2,000
$85.16K
100%
17 Aug 2020
Director
Sold, plan not stated
2,000
$78.77K
100%
15 Jul 2020
Director
Sold, plan not stated
2,000
$87.69K
100%
15 Jun 2020
Director
Sold, plan not stated
2,000
$86.00K
100%
15 May 2020
Director
Sold, plan not stated
2,000
$69.50K
100%
23 Apr 2020
Director
Sold, plan not stated
25,000
$744.25K
100%
18 decisions on file.